The Global Strategy for Asthma Management and Prevention (GINA) has published its annual report on asthma management and prevention. Key recommendations include that adults with asthma should receive combination therapy with an inhaled corticosteroid and a long-acting beta-agonist on an as-needed basis. The recommended option is low-dose budesonide-formoterol, or beclomethasone-formoterol as an alternative treatment. Short-acting inhaled beta agonists as rescue medication is discouraged.